A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease (NCT06809400)
A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to generate evidence of the safety, tolerability, and pharmacokinetics/pharmacodynamics of IV LY4006896 compared with placebo in healthy participants and participants with Parkinson's disease.
Who can join: Review the eligibility criteria below.
Location: Collaborative Neuroscience Network - CNS — Los Alamitos, California
Age range: 30 Years to 85 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (14 Sites)
- Collaborative Neuroscience Network - CNS — Los Alamitos, California
- Collaborative Neuroscience Network - CNS — Los Alamitos, California
- K2 Medical Research, LLC — Maitland, Florida
- Aqualane Clinical Research — Naples, Florida
- Charter Research — Orlando, Florida
- Progressive Medical Research — Port Orange, Florida
- K2 Medical Research, LLC — The Villages, Florida
- Charter Research — The Villages, Florida
- QUEST Research Institute — Farmington Hills, Michigan
- PPD Development, LP — Austin, Texas
- Evergreen Health Research — Kirkland, Washington
- Inland Northwest Research — Spokane, Washington
- P-One Clinic — Hachiōji,
- Oita University Hospital — Yufu,
📞 Contact the Study Coordinator
Phone: (317) 615-4559
Email: LillyTrials@Lilly.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Parkinson Disease
- Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation — Tucson, Arizona
- Parkinson's Disease Progression Study — Aurora, Colorado
- To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications — Birmingham, Alabama
- Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower) — Seattle, Washington
- Automated Imaging Differentiation of Parkinsonism — Birmingham, Alabama
- Study in Parkinson Disease of Exercise — Birmingham, Alabama
Explore by condition: All Parkinson Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.